BMY vs LLY: Side-by-Side Comparison
Compare Bristol-Myers Squibb Company (BMY) and Lilly(Eli) & Company (LLY) side by side: market cap USD 118.71B vs USD 1.08T, P/E 16.3 vs 43.7. Financials, growth and model signals on Bullrun.
| Metric | BMY | LLY |
|---|---|---|
| Company | Bristol-Myers Squibb Company | Lilly(Eli) & Company |
| Country / Exchange | United States · NYSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 118.71B | USD 1.08T |
| P/E ratio | 16.3 | 43.7 |
| Dividend yield | 5.38% | 0.53% |
| Valuation model | 21.4% undervalued | 11.4% overvalued |
| Revenue (FY2025) | USD 48.19B | USD 65.18B |
| Revenue growth YoY | -0.2% | +44.7% |
| Net income | USD 7.05B | USD 20.64B |
| Gross margin | 71.1% | 83.0% |
| Diluted EPS | 3.46 | 22.95 |